$KZR Here's the payout timeline as I understand it.
$6.95 cash per share - to be paid promptly - probably this week or next.
cash CVR - pro-rata share of KZR net cash above $50MM - probably 3-4 months as AUPH wil need to audit KZR financials
drug-related CVR - out in the fture if/when KZR's drug reaches certain milestones
$KZR Equity Corporate Actions Alert #2026 - 307
Information Regarding the Tender Offer of Kezar Life Sciences, Inc. (KZR)
https://www.nasdaqtrader.com/TraderNews.aspx?id=ECA2026-307
The tender offer by Aurinia Pharmaceuticals Inc. $AUPH to acquire all of the outstanding common stock of Kezar Life Sciences, Inc. $KZR is scheduled to expire at 11:59 p.m. ET, on May 8, 2026, unless extended or terminated. The subsequent merger is tentatively scheduled to close prior to the market open on May 11, 2026. In anticipation of the closing, the stock will be halted immediately following the after-hours session at or around 7:50 p.m. on May 8, 2026. If the merger closes as planned, the stock will remain halted on the day of closing (May 11th) and will be suspended effective May 12, 2026.
KZR shareholders will receive $6.955 & one non-transferable CVR for each share held.
$KZR is paying about $2 million to exit its San Francisco lease early, including a $1.3 million cash payment and the loss of its $0.7 million security deposit.
@US_Bull check out my comments on most recent post - I believe tang has a suitor but that suitor said; get rid of this rick head at the helm 🐷 and throw in your other company $KZR and you got a deal 🤝
$AUPH got a feeling Tang has a suitor lined up for AUPH but that suitor wanted $KZR as part of the package ‼️ long term leaps is the way to play this- no point of holding shares and taking up too much of your purchasing power
$AUPH has agreed to acquire $KZR for $6.955 in cash per share plus a Contingent Value Right (CVR). https://notreload.xyz/aurinia-to-acquire-kezar-life-sciences/
